BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Jong Y, Ingola M, Briaire-de Bruijn IH, Kruisselbrink AB, Venneker S, Palubeckaite I, Heijs BPAM, Cleton-Jansen AM, Haas RLM, Bovée JVMG. Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes. Clin Sarcoma Res 2019;9:9. [PMID: 31160965 DOI: 10.1186/s13569-019-0119-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhou LB, Zhang HC, Dong ZG, Wang CC. Chondrosarcoma of the toe: A case report and literature review. World J Clin Cases 2022; 10(25): 9132-9141 [DOI: 10.12998/wjcc.v10.i25.9132] [Reference Citation Analysis]
2 Tong Y, Cui Y, Jiang L, Pi Y, Gong Y, Zhao D. Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study. Front Public Health 2022;10:901680. [DOI: 10.3389/fpubh.2022.901680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bläsius F, Delbrück H, Hildebrand F, Hofmann UK. Surgical Treatment of Bone Sarcoma. Cancers (Basel) 2022;14:2694. [PMID: 35681674 DOI: 10.3390/cancers14112694] [Reference Citation Analysis]
4 Hvinden IC, Cadoux-Hudson T, Schofield CJ, McCullagh JSO. Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations. Cell Rep Med 2021;2:100469. [PMID: 35028610 DOI: 10.1016/j.xcrm.2021.100469] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rimmer RA, Mace JC, Andersen PE, Cetas JS, Ciporen JN, Dogan A, Smith TL, Geltzeiler M. Determinants of survival in sinonasal and skull base chondrosarcoma: An analysis of the National Cancer Database. Int Forum Allergy Rhinol 2021. [PMID: 34704402 DOI: 10.1002/alr.22909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Evans DR, Lazarides AL, Cullen MM, Somarelli JA, Blazer DG 3rd, Visguass JD, Brigman BE, Eward WC. Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study. Ann Surg Oncol 2021. [PMID: 34570333 DOI: 10.1245/s10434-021-10802-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Riva G, Cavallo I, Gandini S, Ingargiola R, Pecorilla M, Imparato S, Rossi E, Mirandola A, Ciocca M, Orlandi E, Iannalfi A. Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy. Cancers (Basel) 2021;13:4423. [PMID: 34503233 DOI: 10.3390/cancers13174423] [Reference Citation Analysis]
8 Zhang Y, Chen Y, Yang C, Seger N, Hesla AC, Tsagkozis P, Larsson O, Lin Y, Haglund F. TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma. Mod Pathol 2021. [PMID: 34108637 DOI: 10.1038/s41379-021-00848-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Zając AE, Kopeć S, Szostakowski B, Spałek MJ, Fiedorowicz M, Bylina E, Filipowicz P, Szumera-Ciećkiewicz A, Tysarowski A, Czarnecka AM, Rutkowski P. Chondrosarcoma-from Molecular Pathology to Novel Therapies. Cancers (Basel) 2021;13:2390. [PMID: 34069269 DOI: 10.3390/cancers13102390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
10 van Gisbergen MW, Zwilling E, Dubois LJ. Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio. Front Oncol 2021;11:653621. [PMID: 34041023 DOI: 10.3389/fonc.2021.653621] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Lohberger B, Glaenzer D, Eck N, Steinecker-Frohnwieser B, Leithner A, Rinner B, Kerschbaum-Gruber S, Georg D. Effects of a combined therapy of bortezomib and ionizing radiation on chondrosarcoma three-dimensional spheroid cultures. Oncol Lett 2021;21:428. [PMID: 33868466 DOI: 10.3892/ol.2021.12689] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wang K, Michelakos T, Wang B, Shang Z, DeLeo AB, Duan Z, Hornicek FJ, Schwab JH, Wang X. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation. Cancer Lett 2021;505:37-48. [PMID: 33582212 DOI: 10.1016/j.canlet.2021.02.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Palubeckaitė I, Venneker S, Briaire-de Bruijn IH, van den Akker BE, Krol AD, Gelderblom H, Bovée JVMG. Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma. Front Mol Biosci 2020;7:566291. [PMID: 33425984 DOI: 10.3389/fmolb.2020.566291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Carrillo-Gálvez AB, Quintero JE, Rodríguez R, Menéndez ST, Victoria González M, Blanco-Lorenzo V, Allonca E, de Araújo Farias V, González-Correa JE, Erill-Sagalés N, Martínez-Zubiaurre I, Hellevik T, Sánchez-Hernández S, Muñoz P, Zurita F, Martín F, Rodríguez-Manzaneque JC, Anderson P. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β. Cell Death Dis 2020;11:985. [PMID: 33203838 DOI: 10.1038/s41419-020-03197-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
15 Li F, Xu J, Zhu Y, Sun L, Zhou R. Analysis of Cells Proliferation and MicroRNAs Expression Profile in Human Chondrosarcoma SW1353 Cells Exposed to Iodine-125 Seeds Irradiation. Dose Response 2020;18:1559325820920525. [PMID: 32362797 DOI: 10.1177/1559325820920525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Venneker S, Kruisselbrink AB, Briaire-de Bruijn IH, de Jong Y, van Wijnen AJ, Danen EHJ, Bovée JVMG. Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status. Cancers (Basel) 2019;11:E1918. [PMID: 31810230 DOI: 10.3390/cancers11121918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
17 van de Sande MAJ, van der Wal RJP, Navas Cañete A, van Rijswijk CSP, Kroon HM, Dijkstra PDS, Bloem JL(. Radiologic differentiation of enchondromas, atypical cartilaginous tumors, and high‐grade chondrosarcomas—Improving tumor‐specific treatment: A paradigm in transit? Cancer 2019;125:3288-91. [DOI: 10.1002/cncr.32404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]